Comments to Shanghai People's Congress on the Regulations of Shanghai Pudong New Area on Promoting Zhangjiang Biomedical Industry Innovation (Draft)
2021-12-22 | Shanghai
Nearly 10 member companies commented on over 20 articles including:
- application and development of human cell & gene therapy
- human genetic resource management
- biological sample bank
- drug production licence application during clinical trial period
- registration service for drugs and medical equipment
- use of imported drugs and medical eqiupment
- customs clearance of R&D items
- bonded R&D and maintenance of medical equipment
- remanufacturing of medical equipment
- sharing of healthcare data
- participation in expert committee
- government procurement support
- talent support
- financial and taxation support
- eco-environmental management